Immix Biopharma News

Immix Biopharma | DEF 14A: Definitive information statements

Apr 29 17:30 ET

Immix Biopharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 20 12:46 ET

Immix Biopharma | 8-K: Current report

Feb 6 09:12 ET

Immix Biopharma | 8-K: Current report

Feb 5 16:38 ET

Immix Biopharma | S-3: Registration statement for specified transactions by certain issuers

Sep 25, 2023 16:15 ET

Immix Biopharma | 8-K: Current report

Aug 22, 2023 16:05 ET

Immix Biopharma | 8-K: Current report

Jul 14, 2023 17:26 ET

Immix Biopharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jun 13, 2023 17:27 ET

Immix Biopharma | 8-K: Current report

Jun 8, 2023 06:05 ET

Immix Biopharma | DEFA14A: Others

Apr 25, 2023 16:58 ET

Immix Biopharma | DEF 14A: Definitive proxy statements

Apr 25, 2023 16:52 ET

Immix Biopharma | 8-K: Current report

Mar 22, 2023 08:42 ET

Immix Biopharma | 8-K/A: Current report (Amendment)

Mar 13, 2023 06:05 ET

Immix Biopharma | 8-K: Current report

Mar 10, 2023 21:48 ET

Immix Biopharma | 8-K: Current report

Jan 18, 2023 17:07 ET

Immix Biopharma | S-3: Registration statement for specified transactions by certain issuers

Jan 3, 2023 16:16 ET

Immix Biopharma | 8-K: Current report

Dec 16, 2022 15:57 ET

Immix Biopharma | 8-K: Current report

Dec 14, 2022 16:05 ET

Immix Biopharma | 8-K: Current report

Jun 9, 2022 08:00 ET

Immix Biopharma | S-1: General form for registration of securities under the Securities Act of 1933

May 27, 2022 16:38 ET